UC Cancer Institute s Breast Cancer Center Receives Accreditation
CincinnatiThe University of Cincinnati Cancer Institutes Comprehensive Breast Cancer Center has received a three-year accreditation by the National Accreditation Program for Breast Centers (NAPBC), a program of the American College of Surgeons.
The NAPBC represents a consortium of national, professional organizations dedicated to the improvement of the quality of care and monitoring of outcomes of patients with diseases of the breast, and accreditation by the program is only granted to centers that have undergone a rigorous evaluation process and review of their performance.
The breast center is the only center in Ohio to have achieved the highest distinction from the American College of Radiology (Breast Imaging Center of Excellence), National Quality Measures for Breast Centers (Certified Quality Breast Center of Excellence) and the NAPBC.
"We are delighted to receive this accreditation, which speaks to the excellence present at the UC Cancer Institute and the quality care delivered by breast cancer specialists within our institution, says Elyse Lower, MD, director of the Comprehensive Breast Cancer Center and a professor in the division of hematology oncology at the UC College of Medicine.
During the survey process, the center must demonstrate compliance with standards established by the NAPBC for treating women who are diagnosed with the full spectrum of breast disease. Standards include proficiency in the areas of center leadership, clinical management, research, community outreach, professional education and quality improvement.
NAPBC-accredited centers must also place emphasis on comprehensive care from a multidisciplinary team as well as patient access to ongoing clinical trials and treatment options.
"This further demonstrates our centers ability to provide superb integrative, cutting-edge breast care to the Tristate, and this accreditation is the result of the extensive efforts of our institutes multidisciplinary specialized clinical team, Lower adds. "This national award is a cornerstone step as we integrate the services of clinical care, clinical investigation and basic research in the UCCI Comprehensive Breast Cancer Center.
For more information about the National Accreditation Program for Breast Centers, visit www.accreditedbreastcenters.org.
Related Stories
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.
Phase 1 trial tests probiotic treatment for radiation side effects in the gut
March 9, 2026
The University of Cincinnati Cancer Center’s Bailey Nelson, MD, has been awarded a $50,000 pilot grant from the Cancer Center to open a Phase 1 trial testing if a probiotic supplement can reduce gastrointestinal symptoms for patients undergoing whole pelvis radiotherapy.
Is uACR the key to cardiovascular and kidney disease prevention?
March 8, 2026
As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.